|
Realtime-Estimate
Cboe BZX
19:07:41 19.11.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 0.4010 USD | -1.69% |
|
-8.86% | -74.61% |
| 14:06 | Outlook Therapeutics, Inc. : Piper Sandler bleibt bei seiner Kaufempfehlung | ZM |
| 09.10. | Outlook Therapeutics ernennt Greg DiPasquale zum Chief Commercial Officer | MT |
ETFs investiert in Outlook Therapeutics, Inc.
| Name | % 1. Jan. | Gewichtung | Volumen | |
|---|---|---|---|---|
| +11.59% | - | 5 739 M€ | ||
| +4.26% | 0.01% | 1 518 M€ | ||
| +5.74% | 0% | 32 130 M€ | ||
| +6.11% | 0% | 20 362 M€ | ||
| +10.83% | 0% | 14 144 M€ | ||
| +4.37% | 0% | 4 204 M€ | ||
| +10.20% | 0% | 12 086 M€ | ||
| -8.15% | 0% | 59 M€ | ||
| +1.20% | 0% | 37 M€ | ||
| +5.73% | 0% | 19 M€ | ||
| +3.16% | 0% | 80 M€ | ||
| 0.00% | 0% | 43 M€ | ||
| +5.02% | 0% | 26 M€ | ||
| +4.26% | 0% | 594 M€ | ||
| -4.24% | 0% | 580 M€ | ||
| +3.34% | 0% | 727 M€ | ||
| +4.42% | 0% | 513 M€ | ||
| +7.40% | 0% | 194 M€ | ||
| +1.13% | 0% | 176 M€ | ||
| +6.16% | -.--% | 156 M€ | ||
| +4.89% | -.--% | 146 M€ | ||
| +8.49% | -.--% | 62 M€ | ||
| -0.05% | -.--% | 18 M€ |
Beschäftigte
17
Sektor
Biotechnologie
- Börse
- Aktien
- A4046T Aktie
- ETFs Outlook Therapeutics, Inc.
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen
















